Esocover-D Capsule SR is a combination pharmaceutical formulation containing Domperidone 30 mg and Esomeprazole 40 mg, designed for the management of gastrointestinal disorders characterized by acid reflux, dyspepsia, and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, effectively reducing gastric acidity and promoting mucosal healing. The sustained-release formulation ensures prolonged therapeutic plasma concentrations, enhancing symptom control and patient compliance. Esocover-D Capsule SR is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and functional dyspepsia, particularly in patients requiring both acid suppression and prokinetic therapy. It is contraindicated in patients with known hypersensitivity to either component, significant hepatic impairment, or prolactin-releasing pituitary tumors. Caution is advised when co-administered with drugs metabolized via CYP3A4 due to potential interactions. The medication should be taken as prescribed, preferably before meals, and under medical supervision to monitor efficacy and adverse effects such as headache, dry mouth, or abdominal discomfort.